USD 206.27
(-0.79%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 360.11 Million | 289.23 Million | 282.09 Million | 404.48 Million | 265.93 Million | 223.91 Million |
Net Income | 258.05 Million | 250.22 Million | 257.88 Million | 299.37 Million | 204.9 Million | 172.85 Million |
Depreciation & Amortization | 76.41 Million | 67.15 Million | 60.24 Million | 42.83 Million | 32.65 Million | 23.08 Million |
Deferred income taxes | -5.81 Million | -6.54 Million | 3.11 Million | 10.09 Million | 2.68 Million | -1.25 Million |
Stock-based compensation | 29.19 Million | 29.86 Million | 27.31 Million | 25.61 Million | 25.29 Million | 15.85 Million |
Change in working capital | 673 Thousand | -43.23 Million | -66 Million | 27.11 Million | 1.19 Million | 11.05 Million |
Other non-cash items | 1.6 Million | -8.22 Million | -466 Thousand | -550 Thousand | -786 Thousand | 2.33 Million |
Investing Cash Flow | -180.53 Million | -86.27 Million | -67.69 Million | 68.86 Million | -122.05 Million | -50.29 Million |
Investments in PPE | -52.44 Million | -51.87 Million | -50.61 Million | -45.62 Million | -34.7 Million | -47.59 Million |
Acquisitions | -78.47 Million | -34.4 Million | -17.07 Million | -23.29 Million | -97.43 Million | 11.7 Million |
Investment purchases | -54.06 Million | -83.92 Million | -7.88 Million | -32.86 Million | -160.82 Million | -336.53 Million |
Sales/Maturities of investments | 4.45 Million | 157.05 Million | 58.08 Million | 170.65 Million | 170.93 Million | 333.79 Million |
Other Investing Activities | -67.48 Million | -73.13 Million | -50.2 Million | 107.17 Million | -30 Thousand | -11.66 Million |
Financing Cash Flow | -147.05 Million | -242.37 Million | -189.77 Million | -145.11 Million | -118.1 Million | -92.67 Million |
Debt repayment | -123.99 Million | -100 Million | -70.34 Million | -578.35 Million | -1.2 Million | - |
Dividends payments | -109.65 Million | -105.94 Million | -99.79 Million | -90.56 Million | -76.23 Million | -62.43 Million |
Common Stock Repurchased | -25.83 Million | -110.94 Million | -63.18 Million | -16.13 Million | -17.25 Million | -33.21 Million |
Common Stock Issuance | -24.89 Million | -22.73 Million | 77.44 Million | 582.36 Million | 1.2 Million | -5.07 Million |
Other Financing Activities | -11.56 Million | -25.49 Million | -33.89 Million | -42.41 Million | -24.61 Million | 2.97 Million |
Accounts receivables | -188.16 Million | -62.76 Million | -141.31 Million | -200.88 Million | -2.96 Million | -5.11 Million |
Accounts payables | 220.69 Million | 86.05 Million | 96.21 Million | 139.33 Million | -1.5 Million | 14.37 Million |
Inventory | - | - | -15.99 Million | 76.37 Million | -1.22 Million | -826 Thousand |
Other working capital | -31.85 Million | -66.52 Million | -4.91 Million | 12.29 Million | 6.88 Million | 2.62 Million |
Cash at beginning of period | 481.69 Million | 625.56 Million | 608.05 Million | 274.25 Million | 247.45 Million | 168.15 Million |
Cash at end of period | 496.4 Million | 572.66 Million | 625.56 Million | 608.05 Million | 274.25 Million | 247.45 Million |
Capital Expenditure | -52.44 Million | -51.87 Million | -50.61 Million | -45.62 Million | -34.7 Million | -47.59 Million |
Effect of forex changes on cash | 7.58 Million | -13.48 Million | -7.1 Million | 5.55 Million | 1.01 Million | -1.64 Million |
Net cash flow / Change in cash | 14.7 Million | -52.9 Million | 17.51 Million | 333.79 Million | 26.79 Million | 79.3 Million |
Free Cash Flow | 307.67 Million | 237.35 Million | 231.47 Million | 358.86 Million | 231.23 Million | 176.32 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 64.93 Million | 72.61 Million | 258.05 Million | 69.62 Million | 54.94 Million | 59.85 Million |
Depreciation & Amortization | 19.99 Million | 19.79 Million | 76.41 Million | 21.17 Million | 19.05 Million | 18.35 Million |
Deferred income taxes | -1.12 Million | -1.33 Million | -5.81 Million | -313 Thousand | -3.06 Million | -1 Million |
Stock-based compensation | 7.98 Million | 7.1 Million | 29.19 Million | 7.33 Million | 7.48 Million | 6.89 Million |
Change in working capital | 18.34 Million | -104.77 Million | 673 Thousand | 46.53 Million | -395 Thousand | 19.17 Million |
Other non-cash items | 37.22 Million | 116.89 Million | 1.6 Million | -829 Thousand | 1.14 Million | 2.12 Million |
Investing Cash Flow | -8.85 Million | -15.57 Million | -180.53 Million | -92.62 Million | -15.85 Million | -15.01 Million |
Investments in PPE | -18.19 Million | -15.16 Million | -52.44 Million | -13.39 Million | -16.07 Million | -12.08 Million |
Acquisitions | - | - | -78.47 Million | -78.47 Million | 10.08 Million | 11.02 Million |
Investment purchases | -2.89 Million | -4.97 Million | -54.06 Million | -1.89 Million | -1.12 Million | -3.85 Million |
Sales/Maturities of investments | 12.22 Million | 4.55 Million | 4.45 Million | 1.14 Million | 1.34 Million | 923 Thousand |
Other Investing Activities | -10.22 Million | -14.63 Million | -67.48 Million | -11.12 Million | -10.08 Million | -11.02 Million |
Financing Cash Flow | -61.47 Million | -52.54 Million | -147.05 Million | -36.27 Million | -23.11 Million | -39.52 Million |
Debt repayment | - | - | -123.99 Million | -3.99 Million | -3.99 Million | - |
Dividends payments | -27.81 Million | -29.48 Million | -109.65 Million | -27.51 Million | -26.89 Million | -26.89 Million |
Common Stock Repurchased | -33.45 Million | -10.14 Million | -25.83 Million | -4.97 Million | -216 Thousand | -155 Thousand |
Common Stock Issuance | -206 Thousand | -12.91 Million | -24.89 Million | -4.76 Million | -216 Thousand | -137 Thousand |
Other Financing Activities | -206 Thousand | -14.89 Million | -11.56 Million | -3.78 Million | 3.99 Million | -12.48 Million |
Accounts receivables | 73.2 Million | 11.24 Million | -188.16 Million | -130.36 Million | -63.87 Million | 80.56 Million |
Accounts payables | -63.77 Million | -79.52 Million | 220.69 Million | 169.47 Million | 82.73 Million | -36.95 Million |
Inventory | - | - | - | 59.34 Million | -24.49 Million | -34.85 Million |
Other working capital | 8.91 Million | -36.49 Million | -31.85 Million | -51.91 Million | 5.23 Million | 10.42 Million |
Cash at beginning of period | 422.3 Million | 496.4 Million | 481.69 Million | 473.09 Million | 557.32 Million | 502.64 Million |
Cash at end of period | 480.2 Million | 422.3 Million | 496.4 Million | 496.4 Million | 588.89 Million | 557.32 Million |
Capital Expenditure | -18.19 Million | -15.16 Million | -52.44 Million | -13.39 Million | -16.07 Million | -12.08 Million |
Effect of forex changes on cash | -488 Thousand | -3.18 Million | 7.58 Million | 9.03 Million | -8.63 Million | 3.83 Million |
Net cash flow / Change in cash | 57.89 Million | -74.09 Million | 14.7 Million | 23.3 Million | 31.56 Million | 54.68 Million |
Free Cash Flow | 91.76 Million | -19.83 Million | 307.67 Million | 130.13 Million | 63.09 Million | 93.31 Million |
CBOE
3883
ESSITY-B
3741
MEDPLUS
JAYBARMARU